Thursday May 3 | GlobeNewswire
Five Prime Therapeutics Announces the Promotion of Aron Knickerbocker ...
Five Prime Therapeutics, Inc. , a leader in the discovery and development of innovative biologics, announced today that it has promoted Aron Knickerbocker to the position of Senior Vice President and Chief Business Officer.
GSK Signs $30m Deal for Asthma, COPD Drugs
GlaxoSmithKline has signed a second collaboration with Five Prime Therapeutics to develop drugs for asthma and COPD.
Five Prime strikes deal with GSK for asthma drug
Five Prime Therapeutics Inc., a San Francisco-based biotechnology company, has entered into a drug discovery collaboration with U.K.-based biotechnology giant GlaxoSmithKline - the second collaboration of its kind between the two companies.
FivePrime Therapeutics, Inc. Inks Second Strategic Alliance With...
SOUTH SAN FRANCISCO, Calif., Apr 17, 2012 -- Five Prime Therapeutics, Inc. , a leader in the discovery and development of innovative biologics, announced today that it has entered into its second strategic drug discovery alliance with GlaxoSmithKline GSK +0.61% within two years.